<p>巴港财富管理在第三季度将其在强生（NYSE:JNJ - 免费报告）股票中的持仓降低了 5.1%，根据其最近向 SEC 提交的 13F 文件。该公司在季度内出售了 11,018 股后，持有 206,778 股强生的股票。强生约占巴港财富管理持有资产的 2.3%，是其第七大持仓。巴港财富管理在强生的持仓在最近一个季度末的价值为 38,341,000 美元。</p>
<p>获取 <strong>强生</strong> 的提醒：</p>
<ul>
<li>降息使这三只收益 ETF 比以往更具吸引力</li>
</ul>
<p>其他一些对冲基金和机构投资者最近也买卖了该公司的股票。Clark Asset Management LLC 在第二季度将其在强生的股份增加了 51.6%。Clark Asset Management LLC 现在拥有 8,884 股强生的股票，价值 1,357,000 美元，此前在该期间内又购买了 3,025 股。北卡罗来纳州财政部长在第二季度将其在强生的股份提高了 8.3%。北卡罗来纳州财政部长现在拥有 1,234,945 股强生的股票，价值 188,638,000 美元，此前在上个季度又收购了 94,957 股。Avanza Fonder AB 在第二季度将其在强生的持仓增加了 2.9%。Avanza Fonder AB 现在拥有 234,647 股强生的股票，价值 35,842,000 美元，此前在上个季度又购买了 6,566 股。Talbot Financial LLC 在第三季度将其在强生的股份增加了 4.6%。Talbot Financial LLC 现在拥有 138,424 股强生的股票，价值 25,667,000 美元，此前在上个季度又购买了 6,143 股。最后，Winnow Wealth LLC 在第二季度购买了强生的新股份，价值约 295,000 美元。69.55% 的股票由机构投资者和对冲基金持有。</p>
<h2>分析师升级和降级</h2>
<p>一些分析师最近对 JNJ 股票发表了看法。华尔街禅在 9 月 13 日的研究报告中将强生的股票评级从 “持有” 上调至 “买入”。瑞银集团在 10 月 14 日的研究报告中将强生的股票目标价从 190.00 美元提高至 214.00 美元，并给予该公司 “买入” 评级。Cowen 在 10 月 14 日的报告中重新发布了对强生股票的 “买入” 评级。加拿大皇家银行在 12 月 17 日的研究报告中为强生股票设定了 240.00 美元的目标价。最后，Stifel Nicolaus 在 10 月 15 日的研究报告中将强生股票的目标价从 165.00 美元提高至 190.00 美元，并给予该股票 “持有” 评级。四位股票研究分析师对该股票给予了强烈买入评级，十四位给予了买入评级，九位给予了持有评级。根据 MarketBeat.com 的数据，该股票目前的平均评级为 “适度买入”，平均目标价为 210.25 美元。</p>
<ul>
<li>辉瑞加大对减肥药物的投资</li>
</ul>
<p><strong>阅读我们关于 JNJ 的最新报告</strong></p>
<h2>强生股票下跌 0.1%</h2>
<p>强生（NYSE:JNJ）股票在周五开盘时为 207.54 美元。该公司的 50 日移动平均线为 199.67 美元，200 日移动平均线为 180.86 美元。该公司的债务与股本比率为 0.50，速动比率为 0.80，流动比率为 1.07。强生的 1 年最低价为 140.68 美元，1 年最高价为 215.18 美元。该股票的市值为 5000.2 亿美元，市盈率为 20.03，市盈增长比率为 2.25，贝塔值为 0.36。</p>
<ul>
<li>5 个医疗保健公司值得关注，因为行业轮动正在全面展开</li>
</ul>
<p>强生（NYSE:JNJ - 获取免费报告）最近一次公布季度财报是在 8 月 30 日，报告每股收益为 2.26 美元。该公司在该季度的收入为 240.2 亿美元。强生的净利润率为 27.26%，股本回报率为 32.73%。股票分析师预计强生在当前年度的每股收益将达到 10.58 美元。</p>
<h2>强生宣布分红</h2>
<p>该公司最近还宣布了季度分红，已于 12 月 9 日支付。11 月 25 日的股东获得了每股 1.30 美元的分红。这相当于年化分红 5.20 美元，分红收益率为 2.5%。除息日期为 11 月 25 日。强生的分红支付比率目前为 50.19%。</p>
<h2>强生公司简介</h2>
<p>（免费报告）</p>
<p>强生是一家总部位于新泽西州新布伦瑞克的跨国医疗保健公司，开发、制造和销售广泛的产品，涵盖制药、医疗设备和以前的消费健康产品。该公司由约翰逊家族于 1886 年创立，已发展成为一个全球医疗保健组织，在世界许多国家开展业务和销售。</p>
<p>该公司的制药业务主要在其扬森研究与开发组织下运作，专注于免疫学、传染病、肿瘤学和神经科学等治疗领域的处方药。</p>
<h2>进一步阅读</h2>
<ul>
<li>五只我们更看好的股票比强生更具吸引力</li>
<li>请勿删除，立即阅读</li>
<li>投资者提醒：微型 “3 美元人工智能奇迹股票” 即将爆发</li>
<li>资本利得税是否可以扣除任何费用？</li>
<li>你知道亚马逊计划在 1 月 1 日做什么吗？</li>
<li>巴菲特、盖茨和贝索斯悄悄抛售股票——原因在这里</li>
</ul>
<p><strong>想看看其他对冲基金持有的 JNJ 吗？</strong> 访问 HoldingsChannel.com 获取强生（NYSE:JNJ - 免费报告）的最新 13F 文件和内部交易。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUpOSg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUpOSg"/></p>
<p><em>此即时新闻提醒由叙事科学技术和来自 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1,000 美元在强生吗？</h2>
<p>在考虑强生之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而强生并不在名单上。</p>
<p>虽然强生目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

强生

<p>巴港财富管理在第三季度减少了对强生的持股比例，下降了 5.1%，出售了 11,018 股，目前持有 206,778 股，市值为 3,834 万美元。强生在他们的投资组合中占比 2.3%。其他投资者也调整了他们的强生持股，分析师给予 “适度买入” 的评级，目标价为 210.25 美元。强生的股票开盘价为 207.54 美元，市值为 5000.2 亿美元</p>

<p>Bar Harbor Wealth Management lowered its position in shares of Johnson &amp; Johnson (NYSE:JNJ - Free Report) by 5.1% in the third quarter, according to its most recent 13F filing with the SEC. The firm owned 206,778 shares of the company's stock after selling 11,018 shares during the quarter. Johnson &amp; Johnson comprises approximately 2.3% of Bar Harbor Wealth Management's holdings, making the stock its 7th largest holding. Bar Harbor Wealth Management's holdings in Johnson &amp; Johnson were worth $38,341,000 at the end of the most recent quarter.</p>
<div class="lb-trans"><p>巴港财富管理在第三季度将其在强生（NYSE:JNJ - 免费报告）股票中的持仓降低了 5.1%，根据其最近向 SEC 提交的 13F 文件。该公司在季度内出售了 11,018 股后，持有 206,778 股强生的股票。强生约占巴港财富管理持有资产的 2.3%，是其第七大持仓。巴港财富管理在强生的持仓在最近一个季度末的价值为 38,341,000 美元。</p>
</div><p>Get <strong>Johnson &amp; Johnson</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>强生</strong> 的提醒：</p>
</div><ul>
<li>Rate Cuts Make These 3 Income ETFs More Attractive Than Ever</li>
</ul>
<div class="lb-trans"><ul>
<li>降息使这三只收益 ETF 比以往更具吸引力</li>
</ul>
</div><p>A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Clark Asset Management LLC increased its stake in Johnson &amp; Johnson by 51.6% during the 2nd quarter. Clark Asset Management LLC now owns 8,884 shares of the company's stock worth $1,357,000 after buying an additional 3,025 shares during the period. Treasurer of the State of North Carolina lifted its stake in shares of Johnson &amp; Johnson by 8.3% in the second quarter. Treasurer of the State of North Carolina now owns 1,234,945 shares of the company's stock worth $188,638,000 after acquiring an additional 94,957 shares in the last quarter. Avanza Fonder AB boosted its holdings in Johnson &amp; Johnson by 2.9% in the second quarter. Avanza Fonder AB now owns 234,647 shares of the company's stock valued at $35,842,000 after purchasing an additional 6,566 shares during the last quarter. Talbot Financial LLC grew its stake in Johnson &amp; Johnson by 4.6% during the 3rd quarter. Talbot Financial LLC now owns 138,424 shares of the company's stock valued at $25,667,000 after purchasing an additional 6,143 shares in the last quarter. Finally, Winnow Wealth LLC purchased a new stake in Johnson &amp; Johnson during the 2nd quarter worth approximately $295,000. 69.55% of the stock is owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>其他一些对冲基金和机构投资者最近也买卖了该公司的股票。Clark Asset Management LLC 在第二季度将其在强生的股份增加了 51.6%。Clark Asset Management LLC 现在拥有 8,884 股强生的股票，价值 1,357,000 美元，此前在该期间内又购买了 3,025 股。北卡罗来纳州财政部长在第二季度将其在强生的股份提高了 8.3%。北卡罗来纳州财政部长现在拥有 1,234,945 股强生的股票，价值 188,638,000 美元，此前在上个季度又收购了 94,957 股。Avanza Fonder AB 在第二季度将其在强生的持仓增加了 2.9%。Avanza Fonder AB 现在拥有 234,647 股强生的股票，价值 35,842,000 美元，此前在上个季度又购买了 6,566 股。Talbot Financial LLC 在第三季度将其在强生的股份增加了 4.6%。Talbot Financial LLC 现在拥有 138,424 股强生的股票，价值 25,667,000 美元，此前在上个季度又购买了 6,143 股。最后，Winnow Wealth LLC 在第二季度购买了强生的新股份，价值约 295,000 美元。69.55% 的股票由机构投资者和对冲基金持有。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析师升级和降级</h2>
</div><p>A number of analysts have recently weighed in on JNJ shares. Wall Street Zen raised shares of Johnson &amp; Johnson from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a research report on Saturday, September 13th. UBS Group increased their price objective on shares of Johnson &amp; Johnson from $190.00 to $214.00 and gave the company a &#34;buy&#34; rating in a research note on Tuesday, October 14th. Cowen reissued a &#34;buy&#34; rating on shares of Johnson &amp; Johnson in a report on Tuesday, October 14th. Royal Bank Of Canada set a $240.00 target price on shares of Johnson &amp; Johnson in a research note on Wednesday, December 17th. Finally, Stifel Nicolaus increased their price target on shares of Johnson &amp; Johnson from $165.00 to $190.00 and gave the stock a &#34;hold&#34; rating in a research report on Wednesday, October 15th. Four equities research analysts have rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and nine have assigned a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of &#34;Moderate Buy&#34; and an average target price of $210.25.</p>
<div class="lb-trans"><p>一些分析师最近对 JNJ 股票发表了看法。华尔街禅在 9 月 13 日的研究报告中将强生的股票评级从 “持有” 上调至 “买入”。瑞银集团在 10 月 14 日的研究报告中将强生的股票目标价从 190.00 美元提高至 214.00 美元，并给予该公司 “买入” 评级。Cowen 在 10 月 14 日的报告中重新发布了对强生股票的 “买入” 评级。加拿大皇家银行在 12 月 17 日的研究报告中为强生股票设定了 240.00 美元的目标价。最后，Stifel Nicolaus 在 10 月 15 日的研究报告中将强生股票的目标价从 165.00 美元提高至 190.00 美元，并给予该股票 “持有” 评级。四位股票研究分析师对该股票给予了强烈买入评级，十四位给予了买入评级，九位给予了持有评级。根据 MarketBeat.com 的数据，该股票目前的平均评级为 “适度买入”，平均目标价为 210.25 美元。</p>
</div><ul>
<li>Pfizer Adds to Its Big Bet on Weight Loss Drugs</li>
</ul>
<div class="lb-trans"><ul>
<li>辉瑞加大对减肥药物的投资</li>
</ul>
</div><p><strong>Read Our Latest Report on JNJ</strong></p>
<div class="lb-trans"><p><strong>阅读我们关于 JNJ 的最新报告</strong></p>
</div><h2>Johnson &amp; Johnson Stock Down 0.1%</h2>
<div class="lb-trans"><h2>强生股票下跌 0.1%</h2>
</div><p>Shares of NYSE:JNJ opened at $207.54 on Friday. The company's fifty day moving average is $199.67 and its two-hundred day moving average is $180.86. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.80 and a current ratio of 1.07. Johnson &amp; Johnson has a 1-year low of $140.68 and a 1-year high of $215.18. The stock has a market capitalization of $500.02 billion, a price-to-earnings ratio of 20.03, a price-to-earnings-growth ratio of 2.25 and a beta of 0.36.</p>
<div class="lb-trans"><p>强生（NYSE:JNJ）股票在周五开盘时为 207.54 美元。该公司的 50 日移动平均线为 199.67 美元，200 日移动平均线为 180.86 美元。该公司的债务与股本比率为 0.50，速动比率为 0.80，流动比率为 1.07。强生的 1 年最低价为 140.68 美元，1 年最高价为 215.18 美元。该股票的市值为 5000.2 亿美元，市盈率为 20.03，市盈增长比率为 2.25，贝塔值为 0.36。</p>
</div><ul>
<li>5 Healthcare Names to Watch as Sector Rotation Is in Full Swing</li>
</ul>
<div class="lb-trans"><ul>
<li>5 个医疗保健公司值得关注，因为行业轮动正在全面展开</li>
</ul>
</div><p>Johnson &amp; Johnson (NYSE:JNJ - Get Free Report) last announced its quarterly earnings data on Wednesday, August 30th. The company reported $2.26 earnings per share for the quarter. The business had revenue of $24.02 billion during the quarter. Johnson &amp; Johnson had a net margin of 27.26% and a return on equity of 32.73%. Equities analysts anticipate that Johnson &amp; Johnson will post 10.58 EPS for the current year.</p>
<div class="lb-trans"><p>强生（NYSE:JNJ - 获取免费报告）最近一次公布季度财报是在 8 月 30 日，报告每股收益为 2.26 美元。该公司在该季度的收入为 240.2 亿美元。强生的净利润率为 27.26%，股本回报率为 32.73%。股票分析师预计强生在当前年度的每股收益将达到 10.58 美元。</p>
</div><h2>Johnson &amp; Johnson Announces Dividend</h2>
<div class="lb-trans"><h2>强生宣布分红</h2>
</div><p>The business also recently declared a quarterly dividend, which was paid on Tuesday, December 9th. Stockholders of record on Tuesday, November 25th were given a dividend of $1.30 per share. This represents a $5.20 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date was Tuesday, November 25th. Johnson &amp; Johnson's dividend payout ratio is presently 50.19%.</p>
<div class="lb-trans"><p>该公司最近还宣布了季度分红，已于 12 月 9 日支付。11 月 25 日的股东获得了每股 1.30 美元的分红。这相当于年化分红 5.20 美元，分红收益率为 2.5%。除息日期为 11 月 25 日。强生的分红支付比率目前为 50.19%。</p>
</div><h2>Johnson &amp; Johnson Company Profile</h2>
<div class="lb-trans"><h2>强生公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Johnson &amp; Johnson is a multinational healthcare company headquartered in New Brunswick, New Jersey, that develops, manufactures and markets a broad range of products across pharmaceuticals, medical devices and previously consumer health. Founded in 1886 by the Johnson family, the company has grown into a global healthcare organization with operations and sales in many countries around the world.</p>
<div class="lb-trans"><p>强生是一家总部位于新泽西州新布伦瑞克的跨国医疗保健公司，开发、制造和销售广泛的产品，涵盖制药、医疗设备和以前的消费健康产品。该公司由约翰逊家族于 1886 年创立，已发展成为一个全球医疗保健组织，在世界许多国家开展业务和销售。</p>
</div><p>The company's pharmaceuticals business, organized largely under its Janssen research and development organization, focuses on prescription medicines across therapeutic areas such as immunology, infectious disease, oncology and neuroscience.</p>
<div class="lb-trans"><p>该公司的制药业务主要在其扬森研究与开发组织下运作，专注于免疫学、传染病、肿瘤学和神经科学等治疗领域的处方药。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>进一步阅读</h2>
</div><ul>
<li>Five stocks we like better than Johnson &amp; Johnson</li>
<li>Do not delete, read immediately</li>
<li>INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off</li>
<li>Can Any Expenses Be Deducted From Capital Gains Tax?</li>
<li>Do you know what Amazon is planning for January 1?</li>
<li>Buffett, Gates and Bezos Quietly Dumping Stocks—Here's Why</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票比强生更具吸引力</li>
<li>请勿删除，立即阅读</li>
<li>投资者提醒：微型 “3 美元人工智能奇迹股票” 即将爆发</li>
<li>资本利得税是否可以扣除任何费用？</li>
<li>你知道亚马逊计划在 1 月 1 日做什么吗？</li>
<li>巴菲特、盖茨和贝索斯悄悄抛售股票——原因在这里</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding JNJ?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Johnson &amp; Johnson (NYSE:JNJ - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他对冲基金持有的 JNJ 吗？</strong> 访问 HoldingsChannel.com 获取强生（NYSE:JNJ - 免费报告）的最新 13F 文件和内部交易。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUpOSg" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=JNJ"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和来自 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Johnson &amp; Johnson Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在强生吗？</h2>
</div><p>Before you consider Johnson &amp; Johnson, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑强生之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Johnson &amp; Johnson wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而强生并不在名单上。</p>
</div><p>While Johnson &amp; Johnson currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然强生目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

巴尔港财富管理公司出售了 11,018 股强生公司股票 $JNJ